Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Maravai Lifesciences Holdings Inc Cl A
(NQ:
MRVI
)
8.670
-0.220 (-2.47%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Maravai Lifesciences Holdings Inc Cl A
< Previous
1
2
3
4
5
6
7
Next >
Maravai Lifesciences Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
July 23, 2021
Maravai Lifesciences sees its Relative Strength Rating enter the 80-plus level.
Via
Investor's Business Daily
Editas Medicine Stock Shows Improved Relative Strength Rating
July 22, 2021
A Relative Strength Rating upgrade for Editas Medicine shows improving technical performance. Will it continue?
Via
Investor's Business Daily
Codex DNA Shares Move Higher On Licensing, Supply Deal With TriLink For mRNA Capping Tech
July 21, 2021
Codex DNA Inc (NASDAQ: DNAY) has announced a licensing and supply agreement with TriLink Biotechnologies, part of Maravai LifeSciences Holdings Inc...
Via
Benzinga
BridgeBio Pharma Stock Sees Rising Relative Strength; Still Shy Of Key Threshold
July 01, 2021
In a welcome move, biotech BridgeBio Pharma stock saw its Relative Strength Rating rise from 70 to 73 on Thursday.
Via
Investor's Business Daily
Translate Bio Stock Sees Relative Strength Rating Jump To 88
June 30, 2021
A Relative Strength Rating upgrade for Translate Bio shows improving technical performance.
Via
Investor's Business Daily
Earnings Scheduled For May 10, 2021
May 10, 2021
Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report...
Via
Benzinga
Translate Bio Stock Flashes Improved Technical Strength Rating; Triple-Digit Sales Growth
June 28, 2021
Translate Bio shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.
Via
Investor's Business Daily
Crispr Therapeutics Stock Sees Improved Relative Strength Rating
June 25, 2021
Crispr Therapeutics stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, rising from 68 to 74.
Via
Investor's Business Daily
The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda
June 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS...
Via
Benzinga
Novan Stock Joins Elite Club Of Stocks With RS Ratings Over 90
June 14, 2021
Novan shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.
Via
Investor's Business Daily
Twist Bioscience Stock Hits 80-Plus Relative Strength Rating Benchmark
June 11, 2021
TwistBioscienceCorp shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 82.
Via
Investor's Business Daily
The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts
June 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 10) Alexion Pharmaceuticals,...
Via
Benzinga
BioNTech SE Stock Earns Membership In 95-Plus Composite Rating Club
June 10, 2021
The IBD SmartSelect Composite Rating for BioNTech SE stock rose from 94 to 97 Thursday. The Covid-19 vaccine stock also has 98 Relative Strength Rating.
Via
Investor's Business Daily
Exposures
COVID-19
Supernus Pharmaceuticals Stock Getting Closer To Key Technical Measure
June 10, 2021
A Relative Strength Rating upgrade for Supernus Pharmaceuticals shows improving technical performance. Will it continue?
Via
Investor's Business Daily
The Daily Biotech Pulse: Hookipa, PDS Biotech Report Positive Data, Ironwood CFO To Depart, Decision Day For Vertex
June 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 7) Agios Pharmaceuticals, Inc...
Via
Benzinga
BridgeBio Stock Flashes Healthy 83 RS Rating
June 02, 2021
Look for stocks with a Relative Strength Rating of 80 or higher. BridgeBio stock just hit that mark, with a jump from 79 to 83 Wednesday.
Via
Investor's Business Daily
Twist Bioscience Stock Scores Relative Strength Rating Upgrade
May 28, 2021
When adding stocks to your watch list, look for stocks with an 80 or higher RS Rating. Twist Bioscience just met that criteria with a new score of 84.
Via
Investor's Business Daily
Cel-Sci Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
May 27, 2021
Cel-Sci stock saw an improvement to its Relative Strength Rating on Thursday, rising from 79 to 87, making the stock a potential watchlist candidate.
Via
Investor's Business Daily
Kalvista Pharmaceuticals Stock Shows Rising Relative Strength
May 19, 2021
A Relative Strength Rating upgrade for Kalvista Pharmaceuticals shows improving technical performance.
Via
Investor's Business Daily
The Daily Biotech Pulse: Iovance To Delay Regulatory Filing For Cancer Therapy, Departures At Passage Bio, Positive Readout For Silence Therapeutics
May 19, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 18) Alexion Pharmaceuticals, Inc...
Via
Benzinga
Horizon Therapeutics Stock Flashes Improved Technical Strength; Nears Buy Point
May 18, 2021
Horizon Therapeutics stock had its Relative Strength Rating upgraded to 75 -- a welcome improvement, but still shy of the 80 or better score you look for.
Via
Investor's Business Daily
Biotech Zai Lab Stock Sees Relative Strength Rating Jump To 83
May 14, 2021
A Relative Strength Rating upgrade for ZaiLabLimited shows improving technical performance.
Via
Investor's Business Daily
Stock Market Rally Struggles With Inflation Spike; Tesla Sales Fall, Elon Musk Turns On Bitcoin As Coinbase Reports
May 14, 2021
The market rally tested key levels as inflation fears mounted. Tesla's China sales dived as CEO Elon Musk dissed Bitcoin.
Via
Investor's Business Daily
Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2021 Earnings Call Transcript
May 11, 2021
MRVI earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
IPO Stock Maravai Lifesciences Crushes First-Quarter Forecasts
May 10, 2021
Late Monday, Maravai reported adjusted income of 26 cents per share on $148.21 million in sales. But the fresh IPO stock was unmoved in after-hours trading.
Via
Investor's Business Daily
Topics
Initial Public Offering
Exposures
Securities Market
Coronavirus Vaccine Plays Moderna, Maravai, West Pharmaceutical Among 5 Stocks Near Buy Points
April 17, 2021
Coronavirus vaccine maker Moderna and vaccine suppliers Maravai and West Pharmaceutical are among five stocks near buy points.
Via
Investor's Business Daily
Topics
Supply Chain
Exposures
COVID-19
Supply Chain
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.